Optibiotix Health Plc LON:OPTI a company formed in 2012 to develop compounds which modify the human microbiome are back in the papers as investors are beginning to see the true potential of the company. The Mail on Sunday wrote “Imagine if a snack bar or fizzy drink could help you to lose weight. Imagine if eating a yogurt could lower your cholesterol, not by a fraction like some existing products, but by more than 70 per cent.” The paper then points out that OptiBiotix Health is well on the way to turning this into reality.
The article is refering to the latest news from Optibiotix Health in which it has set up an agreement with the Instituto de Química Orgánica General of the Spanish National Research Council in Madrid. The agreement means a Scale up to the pipeline of novel oligosaccharides identified by the OptiBiotic® technology platform, Purification of the novel oligosaccharides to the desired level and Analysising the oligosaccharides for taste, texture and aftertaste.
The article states that it expects shares in the company to rise considerably over the next two years as the company’s products hit the market.
Stephen OHara, CEO of OptiBiotix said ‘This article captures the recent progress we have made with our sugar platform in developing calorie free sugars which can have a health benefit. This is a new paradigm that creates the potential to replace conventional ‘unhealthy’ sugars in foods with a calorie free sugar which can help prevent chronic lifestyle diseases like obesity and diabetes’.
